Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice
We have previously demonstrated that the post-stroke administration of iron-free transferrin (apotransferrin, ATf) is beneficial in different models of ischemic stroke (IS) through the inhibition of the neuronal uptake of pro-oxidant iron. In the present study, we asked whether ATf is safe and also...
Saved in:
Main Authors: | Alexia García-Serran (Author), Jesús Ordoño (Author), Núria DeGregorio-Rocasolano (Author), Marc Melià-Sorolla (Author), Karla Odendaal (Author), Octavi Martí-Sistac (Author), Teresa Gasull (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Proteomics Unveils LRRFIP1 as a New Player in the DAPK1 Interactome of Neurons Exposed to Oxygen and Glucose Deprivation
by: Núria DeGregorio-Rocasolano, et al.
Published: (2020) -
The extrahepatic role of TFR2 in iron homeostasis
by: Laura eSilvestri, et al.
Published: (2014) -
Identification of a Novel Inhibitor of TfR1 from Designed and Synthesized Muriceidine A Derivatives
by: Yu Wu, et al.
Published: (2022) -
Targeting Pro-Oxidant Iron with Deferoxamine as a Treatment for Ischemic Stroke: Safety and Optimal Dose Selection in a Randomized Clinical Trial
by: Mònica Millán, et al.
Published: (2021) -
CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration
by: Pawel Stocki, et al.
Published: (2023)